URL : https://www.reuters.com/article/us-health-coronavirus-gilead-remdesivir/gileads-remdesivir-meets-main-goal-of-trial-in-covid-19-patients-idUSKBN22B1T9
ID : RTRS2020042900059

Date : 2020-04-29 12:41:00
Title : Gilead's remdesivir meets main goal of trial in COVID-19 patients
Ariticle : 
(Reuters) - Gilead Sciences Inc said on Wednesday its experimental antiviral drug, remdesivir, had met the main goal of a trial  testing it in COVID-19 patients.  
The trial was being conducted by the National Institute of Allergy and Infectious Diseases (NIAID), and more details on the data would be provided at an upcoming briefing by the NIAID, Gilead said.  